IRIS UniCatt

Bassi, Pierfrancesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 23.739
NA - Nord America 11.014
AS - Asia 7.442
SA - Sud America 1.363
AF - Africa 233
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 20
AN - Antartide 2
Totale 43.848
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 14.650
US - Stati Uniti d'America 10.703
SG - Singapore 3.497
DE - Germania 2.786
CN - Cina 1.676
SE - Svezia 1.503
BR - Brasile 1.082
FR - Francia 1.020
NL - Olanda 900
UA - Ucraina 757
VN - Vietnam 625
GB - Regno Unito 497
IN - India 408
IE - Irlanda 358
PL - Polonia 338
ID - Indonesia 241
FI - Finlandia 207
RU - Federazione Russa 196
JP - Giappone 170
CA - Canada 163
HK - Hong Kong 145
AR - Argentina 110
BD - Bangladesh 110
TR - Turchia 109
CH - Svizzera 99
BE - Belgio 93
ES - Italia 86
IQ - Iraq 71
MX - Messico 70
ZA - Sudafrica 58
PK - Pakistan 47
EC - Ecuador 44
CI - Costa d'Avorio 41
MA - Marocco 37
AT - Austria 36
KR - Corea 35
CO - Colombia 31
VE - Venezuela 29
IR - Iran 27
JO - Giordania 27
RO - Romania 27
PH - Filippine 26
AL - Albania 25
AU - Australia 25
AZ - Azerbaigian 24
LT - Lituania 24
SA - Arabia Saudita 24
UZ - Uzbekistan 22
EG - Egitto 21
MY - Malesia 21
AE - Emirati Arabi Uniti 19
CL - Cile 18
NP - Nepal 15
PY - Paraguay 15
TN - Tunisia 15
HU - Ungheria 14
CZ - Repubblica Ceca 13
GR - Grecia 13
IL - Israele 13
BZ - Belize 12
EU - Europa 12
PA - Panama 12
PE - Perù 12
PT - Portogallo 12
TH - Thailandia 12
CR - Costa Rica 11
DO - Repubblica Dominicana 11
KE - Kenya 11
TW - Taiwan 11
UY - Uruguay 11
BO - Bolivia 10
DZ - Algeria 9
NG - Nigeria 9
RS - Serbia 9
LB - Libano 8
LK - Sri Lanka 8
SN - Senegal 8
BG - Bulgaria 7
BH - Bahrain 7
ET - Etiopia 7
LV - Lettonia 7
TT - Trinidad e Tobago 7
BY - Bielorussia 6
DK - Danimarca 6
NZ - Nuova Zelanda 6
OM - Oman 6
A2 - ???statistics.table.value.countryCode.A2??? 5
HR - Croazia 5
IS - Islanda 5
JM - Giamaica 5
KG - Kirghizistan 5
KZ - Kazakistan 5
LU - Lussemburgo 5
MD - Moldavia 5
NO - Norvegia 5
SM - San Marino 5
HN - Honduras 4
MM - Myanmar 4
NI - Nicaragua 4
SI - Slovenia 4
Totale 43.769
Salva come PNG Salva come JPEG
Città #
Singapore 1.892
Chandler 1.631
Milan 1.436
Rome 1.294
Ashburn 1.166
San Jose 955
Jacksonville 426
Naples 416
Beijing 356
Dublin 346
San Mateo 333
Ann Arbor 318
Los Angeles 306
Florence 267
Turin 251
Wilmington 247
Nanjing 242
Ho Chi Minh City 221
New York 219
Jakarta 218
Warsaw 212
Bologna 206
Lauterbourg 202
Bari 175
Palermo 173
Munich 165
Houston 162
Hanoi 156
Dearborn 153
The Dalles 153
Frankfurt am Main 152
Woodbridge 146
Catania 137
Bremen 130
Boston 128
Nanchang 128
Genoa 126
Hong Kong 126
Nürnberg 125
São Paulo 121
Verona 120
Lawrence 115
Tokyo 113
Fairfield 107
Hefei 104
Chicago 100
Moscow 97
Dallas 95
Marseille 91
Cattolica 90
Redwood City 87
Seattle 85
Kraków 83
Princeton 79
Brussels 76
Brescia 73
Padova 66
Buffalo 62
Helsinki 58
Lancaster 57
Mountain View 55
Santa Clara 55
Venice 55
Cagliari 53
Paris 53
Falls Church 51
Ottawa 50
Amsterdam 49
Parma 48
Council Bluffs 47
Taranto 46
Kunming 45
London 45
Izmir 44
Hyderabad 43
Pescara 43
Reggio Emilia 43
Toronto 43
Orem 42
Redmond 42
Abidjan 41
Bergamo 41
Messina 41
Perugia 41
Tianjin 41
Boardman 37
Salerno 36
Cambridge 35
Livorno 35
Montreal 35
Brooklyn 34
University Park 34
Belo Horizonte 33
Hebei 33
Johannesburg 33
Düsseldorf 32
Haiphong 32
Atlanta 31
Augusta 31
Norwalk 31
Totale 19.033
Salva come PNG Salva come JPEG
Nome #
Le disfunzioni sessuali maschili in pazienti con insufficienza renale cronica end stage ed in pazienti sottoposti a trapianto renale 11.929
Iniezione transuretrale intracervicale di tossina botulinica tipo A nel trattamento della dissinergia del collo vescicale refrattaria a terapia medica 1.221
Iniezione intracervicale di OnabotulinotossinaA per il trattamento dell'ostruzione primitiva del collo vescicale refrattaria alla terapia medica. Una nuova opzione terapeutica 940
Ruolo della risonanza magnetica funzionale (DCE-MRI, DWI-MRI)in pazienti sottoposti a saturation biopsy per persistente sospetto di carcinoma prostatico nonostante un primo set bioptico negativo: risultati preliminari su esperienza monocentrica 907
Il ruolo della chemioimmunoterapia endovescicale nella neoplasia della vescica non muscolo invasiva “ non responder” 609
La tecnologia robotica nel contesto urologico italiano: analisi economica costo-efficacia 423
MALAT1 and HOTAIR long non-coding RNAs play opposite role in estrogen-mediated transcriptional regulation in prostate cancer cells 415
High intensity focused ultrasound (HIFU) in prostate cancer: today’s outcomes and tomorrow’s perspectives 357
Studio trasversale sui sintomi e sulle complicanze del basso apparato urinario e sul loro impatto sulla qualità  della vita connessa alla salute (HRQL) in una coorte di pazienti con sclerosi multipla (MS) utilizzando questionari standardizzati 325
Efficacia di un programma supervisionato perioperatorio di fisioterapia del pavimento pelvico per il miglioramento del recupero della continenza dopo prostatectomia radicale: trial randomizzato controllato 324
High-intensity focused ultrasound in prostate cancer: Today's outcomes and tomorrow's perspectives 315
Pros-IT CNR: an Italian prostate cancer monitoring project 282
H19-Dependent Transcriptional Regulation of β3 and β4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer. 273
E-CADHERIN AND IL-6 SERUM LEVELS IN PATIENTS AFFECTED BY PROSTATE CANCER BEFORE AND AFTER PROSTATECTOMY 262
Le infezioni delle vie urinarie 251
Efficacy of a supervised low-intensity regimen of perioperative pelvic floor muscle training in reducing postprostatectomy urinary incontinence: A randomized controlled trial 248
Do testis germinal tumours express PTTG (Pituitary Transforminf Tumour Gene) 235
(99m)Tc-MAG3 diuretic renography in diagnosis of obstructive nephropathy in adults: a comparison between F-15 and a new procedure F+10(sp) in seated position 231
Metabolic reprogramming by malat1 depletion in prostate cancer 225
SEXUAL DYSFUNCTIONS IN PATIENTS AFFECTED BY MULTIPLE SCLEROSIS: EVALUATION IN A CONTEMPORARY COHORT FROM A REFERRAL CENTER 216
Discovery history and clinical development of mirabegron for the treatment of overactive bladder and urinary incontinence 203
Sexual outcomes after organ potency-sparing surgery and glans reconstruction in patients with penile carcinoma 202
The occult urothelial cancer 199
Soluble E-cadherin and IL-6 serum levels in patients affected by prostate cancer before and after prostatectomy 197
Urological complications following inguinal hernioplasty 197
OnabotulinumtoxinA injection therapy in men with LUTS due to primary bladder-neck dysfunction: objective and patient-reported outcomes 193
KV7 channels in the human detrusor: channel modulator effects and gene and protein expression 187
Evidenze microbiologiche in un singolo centro urologico 184
Robot technology in the Italian Health-CARE system: cost-efficacy economic analysis 184
Complications of Extracorporeal Shock Wave Lithotripsy for Urinary Stones: To Know and to Manage Them–A Review 183
Role of SOCS3 evaluated by immunohistochemical analysis in a cohort of patients affected by prostate cancer: preliminary results 183
Male infertility: non-surgical therapy 177
[Urinary peptides and calcium oxalate nephrolithiasis, a combined approach: MALDI-TOF mass spectrometry and MicroBCA Protein Assay] 175
Silencing of GSTP1, a prostate cancer prognostic gene, by the estrogen receptor-β and endothelial nitric oxide synthase complex 173
Human factors in surgery: from Three Mile Island to the operating room 171
Meccanismo d'azione del bioconiugato idrosolubile paclitaxel-acido ialuronico su linee cellulari umane di tumore della vescica 169
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia treated with intraprostatica onabotulinumtoxinA: 3 month results of a prospective single-armed cohort study 169
[Overactive bladder syndrome: the social and economic perspective] 168
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study 168
Le complicanze nella chirurgia urologica 168
Endourethral migration of a Hem-o-Lok Clip after robot-assisted laparoscopic radical prostatectomy 168
Imaging in prostate cancer diagnosis: present role and future perspectives 167
Size of Bladder Cancers: Correlation among Different Types of Measurement 166
Hot topics in urological health economics. A mini review 165
Bladder and prostate metastasis from small cell lung cancer: a rare entity 165
Extracorporeal shockwave lithotripsy in pediatrics 164
[Foreign bodies in urinary bladder: a clinical case] 163
Therapeutic strategies in penile cancer: state of the art 162
Male sexual dysfunction in patients with chronic end-stage renal insufficiency and in renal transplant recipients 161
(99m)Tc-Mag3 Diuretic Renography In Assessment Of Obstructive Uropathy. The New Test F+10sp: A Step Ahead In The Differential Diagnosis 160
Antibiotic prophylaxis in urology 160
Paraneoplastic Dermatomyositis Associated With Panurothelial Transitional Cell Carcinoma: A Case Report and Literature Review 160
IMAGING IN BLADDER CANCER: PRESENT ROLE AND FUTURE PERPECTIVES.Totaro A, Pinto F, Brescia A, Racioppi M, Cappa E, D'Agostino D, Volpe A, Sacco E, Palermo G, Valentini AL, Bassi PF. 160
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 160
Efficacy of an assisted low-intensity programme of perioperative pelvic floor muscle training in improving the recovery of continence after radical prostatectomy: a randomized controlled trial 159
Postoperative Quality of Life in Patients with Ileal Neobladder at Short-, Intermediate- and Long-Term Follow-Up 159
Microbiological follow-up of nosocomial infections in a single urological center 158
L' era del PCA3: risultati preliminari di uno studio pragmatico monocentrico 157
Germ Cell Neoplasia in situ (GCNIS) in Testis-Sparing Surgery (TSS) for Small Testicular Masses (STMs) 157
Treatment of bladder neck dissynergia with transurethral injection of OnabotulinumtoxinA: objective and patient-reported results 156
Brachytherapy in men with prostate cancer: update on indications and outcomes 156
Positive surgical margins in nephron sparing surgery for renal cell carcinoma 156
Advanced bladder cancer: New agents and new approaches. A review 155
The Clinical Use of Statistical Permutation Test Methodology: A Tool for Identifying Predictive Variables of Outcome 155
Imaging of renal cell carcinoma: state of the art and recent advances 154
Imaging in prostate cancer staging: present role e future perspectives 153
Development of a questionnaire specifically for patients with Ileal Orthotopic Neobladder (IONB) 153
NBI: results review 153
Chirurgia robotica per tutti 152
Hifu as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 152
Circulating tumor cells as prognostic biological marker in different stages prostate cancer and the effect of different therapeutic approaches on their expression 150
Surgery for male urinary incontinence: where are we now and what is in the pipeline? 148
Bradeion (SEPT4) as a Urinary Marker of Transitional Cell Bladder Cancer: A Real-Time Polymerase Chain Reaction Study of Gene Expression 148
H19-Dependent Transcriptional Regulation of beta 3 and beta 4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer 148
Is microsurgical technique really necessary in inguinal or sub-inguinal surgical treatment of varicocele? 147
ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk "bCG failure" non muscle invasive bladder cancer: 3 years follow-up outcomes 146
Advanced bladder cancer: New agents and new approaches. A review 145
[Innovative treatments of non muscle invasive bladder cancer] 145
Clinical, pathological and molecular prognostic factors in prostate cancer decision-making process 144
Neutrophil gelatinase-associated lipocalin (NGAL) value changes before and after shock wave lithotripsy 144
Test F+10 SP: un nuovo metodo angioscintigrafico per la diagnosi dell'uropatia ostruttiva 143
Local relapse of prostate cancer after primary definitive treatment: the management 143
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study 141
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 141
Imaging in prostate cancer staging: present role and future perspectives 141
Circumcision: history, religion and law 140
Stone composition and vascular calcifications in patients with nephrolithiasis 140
Imaging in Prostate Cancer Diagnosis: Present Role and Future Perspectives. 140
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 139
Inhibition of prostate efferent neurotransmission by amikacin 139
High intensity focused ultrasound as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 139
HER-2 immunohistochemical expression as prognostic marker in high-grade T1 bladder cancer (T1G3) 138
Thermochemotherapy for non-muscle-invasive bladder cancer: is there a chance to avoid early cystectomy? 137
Histopathological Ratios to Predict Gleason Score Agreement between Biopsy and Radical Prostatectomy 137
Postoperative nomogram for invasive bladder cancer: Does it really work? A multicenter cohort study 136
Is extracorporeal shock wave lithotripsy in pediatrics a safe procedure? 134
Bladder pain syndrome associated with highest impact on sexual function among women with lower urinary tract symptoms 134
Calcium oxalate nephrolithiasis: urinary "medium size peptides"analysis using MALDI-TOF mass spectrometry. 133
InTrathecal mORphine, traNsversus Abdominis Plane Block, and tramaDOl Infusion for Catheter-Related Bladder Discomfort in Patients Undergoing Robot-Assisted Laparoscopic Prostatectomy (TORNADO): A Pilot Prospective Controlled Study 133
Mitomycin C: new strategies to improve efficacy of a well-known therapy 132
Totale 32.629
Salva come PNG Salva come JPEG
Categoria #
all - tutte 128.646
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 128.646
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021518 0 0 0 0 0 0 0 0 0 108 305 105
2021/20222.276 218 147 77 182 186 112 79 297 138 161 304 375
2022/20235.995 686 637 419 779 341 641 270 479 639 280 480 344
2023/20246.891 384 811 433 550 478 598 528 628 449 613 641 778
2024/20259.615 640 753 881 716 953 638 643 723 1.104 746 994 824
2025/202610.816 1.722 482 702 1.115 1.886 654 2.072 645 753 785 0 0
Totale 44.262